Ionis Pharmaceuticals Inc. (IONS) on GreekSoup https://greeksoup.ai/stocks/us/ions/ Every dated entry in the public record on Ionis Pharmaceuticals Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Ionis Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/ions/filings/us:IONS:filing:2026-10-23:1ad7c80c76Fri, 23 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/ions/filings/us:IONS:filing:2026-10-21:e845a0ed31Wed, 21 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: Devers Shannon L. (EVP, Chief Human Resources Ofc) sold 1,357 shares at $43.54 on 16 October 2026, $59,082https://greeksoup.ai/stocks/us/ions/insiders/us:IONS:insider:2026-10-19:17372fde99Mon, 19 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: Swayze Eric (EVP Research), by Son, sold 53 shares at $43.54 on 16 October 2026, $2,308https://greeksoup.ai/stocks/us/ions/insiders/us:IONS:insider:2026-10-19:dcdafb0287Mon, 19 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: Form 144, Devers Shannon L. plans to sell 1,357 shares worth $59,708 around 16 October 2026https://greeksoup.ai/stocks/us/ions/planned-sales/us:IONS:planned-sale:2026-10-16:3ba2b77c39Fri, 16 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: short interest 20,653,026 shares at the 15 October 2026 settlement, 7.65 days to coverhttps://greeksoup.ai/stocks/us/ions/short-interest/us:IONS:short-interest:2026-10-15:d78d7eaa83Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: short interest 22,508,744 shares at the 30 September 2026 settlement, 4.61 days to coverhttps://greeksoup.ai/stocks/us/ions/short-interest/us:IONS:short-interest:2026-09-30:fe363f5c22Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/ions/filings/us:IONS:filing:2026-09-23:b2243a2c38Wed, 23 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: short interest 20,890,252 shares at the 15 September 2026 settlement, 5.20 days to coverhttps://greeksoup.ai/stocks/us/ions/short-interest/us:IONS:short-interest:2026-09-15:2d200baa75Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/ions/filings/us:IONS:filing:2026-09-04:f308dc1dc6Fri, 04 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/ions/filings/us:IONS:filing:2026-09-04:cb90109010Fri, 04 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: short interest 20,924,638 shares at the 31 August 2026 settlement, 9.18 days to coverhttps://greeksoup.ai/stocks/us/ions/short-interest/us:IONS:short-interest:2026-08-31:39318f2a9eMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: short interest 20,909,181 shares at the 14 August 2026 settlement, 9.62 days to coverhttps://greeksoup.ai/stocks/us/ions/short-interest/us:IONS:short-interest:2026-08-14:f3a8b9515dFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/ions/filings/us:IONS:filing:2026-07-31:43060d0d94Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: Hayden Michael R (Director), by Spouse, bought 5,000 shares at $51.60 on 31 July 2026, $258,000https://greeksoup.ai/stocks/us/ions/insiders/us:IONS:insider:2026-07-31:d736533cd3Fri, 31 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: Hayden Michael R (Director), by Spouse, bought 15,000 shares at $53.38 on 30 July 2026, $800,700https://greeksoup.ai/stocks/us/ions/insiders/us:IONS:insider:2026-07-31:692fddd317Fri, 31 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ionis Pharmaceuticals Inc.: short interest 21,466,123 shares at the 31 July 2026 settlement, 6.35 days to coverhttps://greeksoup.ai/stocks/us/ions/short-interest/us:IONS:short-interest:2026-07-31:a99c312bb9Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>